Armata Pharmaceuticals

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$1,159
$2,169
$491
$1,235
Gross Profit
789
1,803
114
855
EBITDA
-21,959
-12,121
-2,552
6,260
EBIT
-22,329
-12,487
-2,929
5,880
Net Income
-26,675
-16,295
-6,531
2,600
Net Change In Cash
1,159
2,169
491
1,235
Free Cash Flow
-4,540
-7,360
-7,679
-7,850
Cash
14,756
4,328
11,688
9,291
Basic Shares
36,226
36,193
36,185
59,082

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$5,174
$4,529
$5,508
$4,474
Gross Profit
-29,252
3,557
-29,509
-15,541
EBITDA
-41,111
-65,447
-36,054
-21,922
EBIT
-42,436
-66,419
-36,946
-23,091
Net Income
-18,916
-69,045
-36,917
-23,155
Net Change In Cash
5,174
4,529
5,508
4,474
Cost of Revenue
9,324
639
Free Cash Flow
-39,430
-55,567
-34,692
-24,879
Cash
9,291
13,523
14,852
10,288
Basic Shares
36,160
36,076
34,294
24,104

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
-$0.74
2025-06-30
-$0.45
2025-03-31
-$0.19